Memphasys’ resource centre provides news and articles on Memphasys.

The news content is broken into three simple categories to enable easier navigation. A search function is also available to enable specific searches.

News is classified into four sections below: Publications, News and articles, Technology Developments, White Papers and Research and Awards and Case Studies.

Memphasys Limited (ASX: MEM) is an Australian-based reproductive biotechnology company commercialising the Felix™ System, a patented bio separation technology that isolates the most viable sperm cells for human assisted reproduction.

For investor and media enquiries:
David Tasker, Chapter One Advisors
E: dtasker@chapteroneadvisors.com.au
M: +61 433 112 936

Find

Level 1, 34-36 Richmond Road,
Homebush West, NSW 2140
Australia

Call

Privacy Preference Center